Aprocitentan, A Dual Endothelin Receptor Antagonist Under Development for the Treatment of Resistant Hypertension
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6544
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Aprocitentan, A Dual Endothelin Receptor Antagonist Under Development for the Treatment of Resistant Hypertension ; day:12 ; month:7 ; year:2021 ; pages:1-10
Cardiology and therapy ; (12.7.2021), 1-10
- Urheber
-
Angeli, Fabio
Verdecchia, Paolo
Reboldi, Gianpaolo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40119-021-00233-7
- URN
-
urn:nbn:de:101:1-2021101706284624800577
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Angeli, Fabio
- Verdecchia, Paolo
- Reboldi, Gianpaolo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension
Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension
Dual Endothelin Antagonism with Aprocitentan as a Novel Therapeutic Approach for Resistant Hypertension
Structural basis of antagonist selectivity in endothelin receptors
Effekt von Endothelin-1 und Endothelin-A-Rezeptor-Antagonist auf die Mikrozirkulation bei TNBS-Colitis
Der duale Endothelin-Rezeptor-Antagonist Bosentan inhibiert die TNF-alpha-induzierte GM-CSF-Expression in humanen glatten Bronchialmuskelzellen
Treatment of nonarteritic anterior ischemic optic neuropathy with an endothelin antagonist: ENDOTHELION (ENDOTHELin antagonist receptor in Ischemic Optic Neuropathy)—a multicentre randomised controlled trial protocol
Macitentan: entry-into-humans study with a new endothelin receptor antagonist
Single-dose pharmacokinetics, safety, and tolerability of the dual endothelin receptor antagonist aprocitentan in subjects with moderate hepatic impairment
Effect of the dual endothelin receptor antagonist bosentan on untreatable skin ulcers in a patient with diabetes: a case report
Synthesis of a 5HT7/5HT2 Dual Antagonist
Endothelin receptor antagonist improves donor lung function in an ex vivo perfusion system
Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension
Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension
Dual Endothelin Antagonism with Aprocitentan as a Novel Therapeutic Approach for Resistant Hypertension
Structural basis of antagonist selectivity in endothelin receptors
Effekt von Endothelin-1 und Endothelin-A-Rezeptor-Antagonist auf die Mikrozirkulation bei TNBS-Colitis
Der duale Endothelin-Rezeptor-Antagonist Bosentan inhibiert die TNF-alpha-induzierte GM-CSF-Expression in humanen glatten Bronchialmuskelzellen
Treatment of nonarteritic anterior ischemic optic neuropathy with an endothelin antagonist: ENDOTHELION (ENDOTHELin antagonist receptor in Ischemic Optic Neuropathy)—a multicentre randomised controlled trial protocol
Macitentan: entry-into-humans study with a new endothelin receptor antagonist
Single-dose pharmacokinetics, safety, and tolerability of the dual endothelin receptor antagonist aprocitentan in subjects with moderate hepatic impairment
Effect of the dual endothelin receptor antagonist bosentan on untreatable skin ulcers in a patient with diabetes: a case report
Synthesis of a 5HT7/5HT2 Dual Antagonist
Endothelin receptor antagonist improves donor lung function in an ex vivo perfusion system
Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension
Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension
Dual Endothelin Antagonism with Aprocitentan as a Novel Therapeutic Approach for Resistant Hypertension
Structural basis of antagonist selectivity in endothelin receptors
Effekt von Endothelin-1 und Endothelin-A-Rezeptor-Antagonist auf die Mikrozirkulation bei TNBS-Colitis
Der duale Endothelin-Rezeptor-Antagonist Bosentan inhibiert die TNF-alpha-induzierte GM-CSF-Expression in humanen glatten Bronchialmuskelzellen
Treatment of nonarteritic anterior ischemic optic neuropathy with an endothelin antagonist: ENDOTHELION (ENDOTHELin antagonist receptor in Ischemic Optic Neuropathy)—a multicentre randomised controlled trial protocol
Macitentan: entry-into-humans study with a new endothelin receptor antagonist
Single-dose pharmacokinetics, safety, and tolerability of the dual endothelin receptor antagonist aprocitentan in subjects with moderate hepatic impairment
Effect of the dual endothelin receptor antagonist bosentan on untreatable skin ulcers in a patient with diabetes: a case report
Synthesis of a 5HT7/5HT2 Dual Antagonist